Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Immediately after opening, your secured card can influence factors like payment history and utilization. Here’s what to expect in the first months.
19,050 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Aveanna's Q1 2026 results shed light on how the company is navigating labor costs, payer mix, and geographic expansio...
Shimmick's Q1 2026 results offer a window into infrastructure demand and cost pressures. This article breaks down the...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
A standout move in the world of investing: a wealth manager makes a sizable bet on an active international rotation E...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
The House approves a bipartisan home affordability bill aimed at accelerating home construction and limiting corporat...
Shoe Carnival's Q1 2026 results offer early clues about its path through promotions, online growth, and inventory man...
Gas prices hover near fresh highs as families hit the road for the summer travel rush. A simple trio—drive slower, el...
With summer on the horizon, investors wonder if XLE should ride along in their portfolios. This guide weighs the case...
A stubborn drought threatens the nation’s largest oil export hub in Corpus Christi, forcing lawn bans and possible em...